Brief: Amneal Receives FDA Approval for Propofol Injectable Emulsion Single Dose Vials
20/08/2024 13:27
Aug 20 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL RECEIVES U.S. FDA APPROVAL FOR PROPOFOL INJECTABLE
EMULSION SINGLE DOSE VIALS
* AMNEAL PHARMACEUTICALS INC - EXPECTS TO LAUNCH PROPOFOL IN
Q4 OF
2024
Source text for Eikon: ID:nBw6Q4zWva
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study